Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|February 1, 1979
Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B studyL A White, M C Perry, C G Kardinal, et al.
Cancer|February 15, 1989
Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variablesD B Tritz, D C Doll, Q S Ringenberg, et al.
Scientific Reports|May 24, 2020
The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibilityA Mohammadi, S Bagherichimeh, M C Perry, et al.
International Journal of Sports Medicine|September 15, 2005
Number of repetitions to maximum in hop tests in patients with anterior cruciate ligament injuryM C Perry, M C Morrissey, J S Jones, et al.
American Journal of Clinical Oncology|October 1, 1992
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group BA P Lyss, M C Perry, M Goutsou, et al.
Cancer Treatment Reports|September 1, 1981
Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomasG J Vosika, K Briscoe, R W Carey, et al.
Cancer|February 1, 1995
Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer and Leukemia Group BD T Kiang, B J Kennedy, J Younger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patientsD Spiegelman, L H Maurer, J H Ware, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group BE E Vokes, A P Lyss, J E Herndon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1995
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B studyJ J Muscato, C Cirrincione, G Clamon, et al.
Pageof 11